The cell based assays market is projected to reach USD 18.9 billion by 2024 from USD 13.9 billion in 2019, at a CAGR of 6.3%.
The Research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Cell Based Assay Market, along with revenue estimates & forecasts and market share analysis.
The growth of this market is majorly driven by the growing preference for cell-based assays, increasing research funding, and the growth in the number of drug discovery activities.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=119917269
Cell Based Assay Market segmentation:
- Based on Product & Services
- Based on Application
- Based on End Users
- Based on Regions.
The Major Players Opearting in the Cell Based Assay Market:
Key players in the Cell Based Assay Market include Thermo Fisher Scientific, Inc. (US), Danaher Corporation (Beckman Coulter, Inc.) (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KGaA (Germany), Lonza Group (Switzerland), PerkinElmer, Inc. (US), Charles River Laboratories, Inc. (US), Cell Signaling Technologies (US), Cisbio (US), Cell Biolabs, Inc. (US), and Promega Corporation (US).
Thermo Fisher Scientific was the leading player in the global Cell Based Assay Market.
The company offers a range of assay kits and cell lines used in cell-based assays. The company‘s large share in this market can be attributed to its extensive product portfolio and strong sales & distribution network. Thermo Fisher focuses on developed and emerging markets in order to generate a significant amount of its revenue. The company registered 57.7% of its total revenue from the US and China together. In order to maintain its leading position in the market, the company also invests 3–5% of its total revenue on R&D.
Geographical Detailed Analysis for Cell Based Assay Market:
North America is the largest regional segment in the Cell Based Assay Market.
The large share of North America in this market can be attributed to the increasing R&D activities by biopharma companies and increasing presence of these companies in the US is expected to increase the demand for cell-based assays product and services in this region.
Read More in Detailed (Cell Based Assay):